OTCMKTS:EXETF Extendicare (EXETF) Stock Price, News & Analysis → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free EXETF Stock Alerts $5.79 +0.49 (+9.25%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$5.65▼$5.7950-Day Range$5.28▼$5.8352-Week Range$4.10▼$5.83Volume2,649 shsAverage Volume4,768 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.29%Price TargetN/A Stock AnalysisStock AnalysisChartDividendHeadlinesShort InterestStock AnalysisChartDividendHeadlinesShort Interest Get Extendicare alerts: Email Address Extendicare MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.00Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.01 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Extendicare.Read more about Extendicare's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 250.6, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently decreased by 3.86%, indicating that investor sentiment is improving. Previous Next 1.7 Dividend Strength Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Read more about Extendicare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EXETF. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 3 news articles for Extendicare this week, compared to 0 articles on an average week.MarketBeat Follows1 people have added Extendicare to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 9.44% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is -22.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is -22.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Timothy SykesBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthless $2 stock…>>Click here to discover why Bill Gates is all about this tiny $2 stock. About Extendicare Stock (OTCMKTS:EXETF)Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More EXETF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EXETF Stock News HeadlinesMay 16 at 7:12 AM | finanznachrichten.deExtendicare Inc: Extendicare Announces 2024 First Quarter ResultsMay 16 at 2:29 AM | americanbankingnews.comExtendicare (OTCMKTS:EXETF) Trading Up 1.9%May 15, 2024 | globenewswire.comExtendicare Announces 2024 First Quarter ResultsApril 15, 2024 | globenewswire.comExtendicare Announces April 2024 Dividend of C$0.04 per ShareMarch 27, 2024 | finance.yahoo.comOntario Nurses' Association Pickets at Extendicare Canada to Launch Nursing Homes Bargaining Campaign Calling for Care, Not ProfitMarch 15, 2024 | msn.comKingston looks at primary health clinic option for former Extendicare facilityMarch 7, 2024 | globenewswire.comExtendicare Announces 2023 Fourth Quarter and Year End ResultsFebruary 29, 2024 | wsj.comExtendicare Inc.February 15, 2024 | prnewswire.comExtendicare Opens the MarketFebruary 15, 2024 | globenewswire.comExtendicare Announces February 2024 Dividend of C$0.04 per ShareFebruary 5, 2024 | msn.comNeighbours oppose plans for supportive housing at Kingston Extendicare facilityFebruary 2, 2024 | msn.comCity of Kingston buys Extendicare facility, supportive housing plannedJanuary 22, 2024 | msn.comExtendicare Kirkland Lake declares suspected enteric outbreakJanuary 10, 2024 | msn.comExtendicare Kirkland Lake declares COVID-19 outbreakNovember 13, 2023 | seekingalpha.comExtendicare Inc. (EXETF) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Third Quarter ResultsNovember 8, 2023 | finance.yahoo.comThose who invested in Extendicare (TSE:EXE) five years ago are up 19%October 6, 2023 | markets.businessinsider.comExtendicare Announces Timing of 2023 Third Quarter Results and Conference CallSeptember 13, 2023 | finance.yahoo.comShould You Investigate Extendicare Inc. (TSE:EXE) At CA$6.16?August 17, 2023 | markets.businessinsider.comRBC Capital Keeps Their Hold Rating on Extendicare (EXE)August 11, 2023 | msn.comWorkers at Extendicare Kingston on information picket line over payroll issuesAugust 11, 2023 | finanznachrichten.deExtendicare Inc: Extendicare Announces 2023 Second Quarter ResultsAugust 11, 2023 | markets.businessinsider.comExtendicare Announces 2023 Second Quarter ResultsJuly 16, 2023 | theglobeandmail.comExtendicare: Stocks Overvalued by Analyst Consensus on TSX (EXE)July 6, 2023 | benzinga.comExtendicare Announces Timing of 2023 Second Quarter Results and Conference CallSee More Headlines Receive EXETF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/15 Dividend3/27/2024Dividend Payable4/15/2024Ex-Dividend for 5/15 Dividend4/29/2024Dividend Payable5/15/2024Today5/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryN/A Current SymbolOTCMKTS:EXETF CUSIPN/A CIKN/A Webwww.extendicare.com Phone(905) 470-4000FaxN/AEmployees23,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesDr. Michael R. Guerriere M.D. (Age 59)MBA, CEO, President & Director Comp: $887.72kMr. David E. BaconSenior VP & CFOMr. Steve ParaskevopoulosSenior Vice President of ParaMed & CTOMr. John ToffolettoSenior VP, Chief Legal Officer & Corporate SecretaryDr. Matthew MorganChief Medical OfficerJoe BelinskyVP of Information Technology & Chief Information OfficerMs. Jillian E. FountainVice President of Investor RelationsMs. Kathryn Killoran BradleyVice President of Corporate DevelopmentMs. Katie LeMoyneSenior VP & Chief Human Resources OfficerMs. Wendy GilmourSenior Vice President of Long-term Care OperationsMore ExecutivesKey CompetitorsAmerican Oncology NetworkNASDAQ:AONCWAmerican Oncology NetworkNASDAQ:AONCBangkok Dusit Medical Services PublicOTCMKTS:BDULFBumrungrad Hospital PublicOTCMKTS:BUHPFCareRxOTCMKTS:CHHHFView All Competitors EXETF Stock Analysis - Frequently Asked Questions How have EXETF shares performed in 2024? Extendicare's stock was trading at $5.4940 at the beginning of 2024. Since then, EXETF shares have increased by 5.4% and is now trading at $5.79. View the best growth stocks for 2024 here. Are investors shorting Extendicare? Extendicare saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 469,100 shares, a decline of 20.8% from the March 31st total of 592,200 shares. Based on an average daily volume of 1,800 shares, the short-interest ratio is currently 260.6 days. View Extendicare's Short Interest. How often does Extendicare pay dividends? What is the dividend yield for Extendicare? Extendicare announced a dividend on Saturday, April 20th. Investors of record on Tuesday, April 30th will be given a dividend of $0.0291 per share on Wednesday, May 15th. This represents a yield of 6.61%. The ex-dividend date is Monday, April 29th. Read our dividend analysis for EXETF. Is Extendicare a good dividend stock? Extendicare (OTCMKTS:EXETF) pays an annual dividend of $0.48 per share and currently has a dividend yield of 8.00%. EXETF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for EXETF. How do I buy shares of Extendicare? Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:EXETF) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBill Gates is all about this tiny $2 stockTimothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingBuy this small stock before coming AI Tidal WaveChaikin AnalyticsShocking $16T Elon Musk Crypto LeakCrypto 101 Media[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
